<DOC>
	<DOCNO>NCT02183792</DOCNO>
	<brief_summary>Hyponatremia common find acute heart failure ( HF ) patient associated bad prognosis . In addition prognostic value , hyponatremia may importance acute management HF . We 've recently show acute chronic hyponatremia , especially &lt; 130 mEq/L , associate high loop diuretic dose requirement frequent need escalation diuretic regimen achieve level diuresis normonatremic HF patient . Aquaresis tolvaptan represent potentially advantageous approach management volume overload HF , especially patient present concomitant hyponatremia . The purpose current study prospectively evaluate comparative efficacy safety tolvaptan-based diuretic regimen compare conventional diuresis furosemide-based regimen short-term clinical treatment outcome hyponatremic acute HF patient . This prospective , open-label , parallel-group , randomize study compare tolvaptan-based aquaretic regimen conventional continuous infusion loop diuretic-based regimen furosemide . Up 55 ( target sample size 50 ) adult subject admit acute HF sign volume overload , serum sodium le 135 mEq/L randomize tolvaptan furosemide treatment arm . The initial 24 hour study treatment compare tolvaptan monotherapy furosemide monotherapy . After initial 24 hour , treatment regimen may alter achieve desire clinical goal . Patients follow 96 hour discharge study purpose .</brief_summary>
	<brief_title>Aquaresis Utility Hyponatremic Acute Heart Failure Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Acute HF sign symptom volume overload [ i.e . elevate jugular venous pulsation ( JVP ) , rale , edema ] Serum sodium &lt; 135 mEq/L time within first 48 hour hospitalization Randomized within 48 hour presentation hospital â‰¥ 18 year age Informed consent Severe symptomatic hyponatremia require acute treatment Severe renal impairment upon admission ( creatinine clearance &lt; 20 mL/min ) Renal replacement therapy dependent , require upon admission Acute coronary syndrome admission Requires mechanical circulatory support device Evidence cardiogenic shock require intravenous vasopressor Pregnancy Patient require concomitant use strong CYP3A4 inhibitor ( clarithromycin , ketoconazole , itraconazole , ritonavir , indinavir , nelfinavir , saquinavir , nefazodone , telithromycin )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>